<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30916123</article-id><article-id pub-id-type="pmc">6436784</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0313</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Coronary Artery Bypass Surgery in Brazil: Analysis of the National
Reality Through the BYPASS Registry</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5860-901X</contrib-id><name><surname>Paez</surname><given-names>Rodrigo Pereira</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Hossne Junior</surname><given-names>Nelson Am&#x000e9;rico</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, MSc</role></contrib><contrib contrib-type="author"><name><surname>Santo</surname><given-names>Jos&#x000e9; Amalth do Esp&#x000ed;rito</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Berwanger</surname><given-names>Otavio</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Renato Hideo Nakagawa</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Kalil</surname><given-names>Renato Abdala Karam</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD, MSc, PhD</role></contrib><contrib contrib-type="author"><name><surname>Jatene</surname><given-names>Fabio B.</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Cavalcanti</surname><given-names>Alexandre Biasi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Zilli</surname><given-names>Alexandre Cabral</given-names></name><xref ref-type="aff" rid="aff5">5</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Bettiati Jr</surname><given-names>Luiz Carlos</given-names></name><xref ref-type="aff" rid="aff5">5</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Figueira</surname><given-names>Fernando Augusto Marinho dos Santos</given-names></name><xref ref-type="aff" rid="aff6">6</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>D'Azevedo</surname><given-names>Stephanie Steremberg Pires</given-names></name><xref ref-type="aff" rid="aff6">6</xref><role>RN</role></contrib><contrib contrib-type="author"><name><surname>Soares</surname><given-names>Marcelo Jos&#x000e9; Ferreira</given-names></name><xref ref-type="aff" rid="aff7">7</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Fernandes</surname><given-names>Marcio Pimentel</given-names></name><xref ref-type="aff" rid="aff7">7</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Ardito</surname><given-names>Roberto Vito</given-names></name><xref ref-type="aff" rid="aff8">8</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Bogdan</surname><given-names>Renata Andrea Barberio</given-names></name><xref ref-type="aff" rid="aff8">8</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Campagnucci</surname><given-names>Valqu&#x000ed;ria Pelisser</given-names></name><xref ref-type="aff" rid="aff9">9</xref><role>MD, MSc, PhD</role></contrib><contrib contrib-type="author"><name><surname>Nakasako</surname><given-names>Diana</given-names></name><xref ref-type="aff" rid="aff9">9</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Rodrigues</surname><given-names>Clarissa Garcia</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>RN, MSc, PhD</role></contrib><contrib contrib-type="author"><name><surname>Rodrigues Junior</surname><given-names>Anilton Bezerra</given-names></name><xref ref-type="aff" rid="aff10">10</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Cascudo</surname><given-names>Marcelo Matos</given-names></name><xref ref-type="aff" rid="aff10">10</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Atik</surname><given-names>Fernando Antibas</given-names></name><xref ref-type="aff" rid="aff11">11</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Lima</surname><given-names>Elson Borges</given-names></name><xref ref-type="aff" rid="aff11">11</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Nina</surname><given-names>Vinicius Jos&#x000e9; da Silva</given-names></name><xref ref-type="aff" rid="aff12">12</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Heluy</surname><given-names>Renato Albuquerque</given-names></name><xref ref-type="aff" rid="aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Azeredo</surname><given-names>Lisandro Gon&#x000e7;alves</given-names></name><xref ref-type="aff" rid="aff13">13</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Henrique Junior</surname><given-names>Odilon Silva</given-names></name><xref ref-type="aff" rid="aff13">13</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>de Mendon&#x000e7;a</surname><given-names>Jos&#x000e9; Teles</given-names></name><xref ref-type="aff" rid="aff14">14</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Katharina Kelly de Oliveira Gama</given-names></name><xref ref-type="aff" rid="aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Pandolfo</surname><given-names>Marcelo</given-names></name><xref ref-type="aff" rid="aff15">15</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>de Lima J&#x000fa;nior</surname><given-names>Jos&#x000e9; Dantas</given-names></name><xref ref-type="aff" rid="aff15">15</xref><role>MD, MSc</role></contrib><contrib contrib-type="author"><name><surname>Faria</surname><given-names>Renato Max</given-names></name><xref ref-type="aff" rid="aff16">16</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>dos Santos</surname><given-names>Jonas Gon&#x000e7;alves</given-names></name><xref ref-type="aff" rid="aff16">16</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Coelho</surname><given-names>Guilherme Henrique Biachi</given-names></name><xref ref-type="aff" rid="aff17">17</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>Sergio Nunes</given-names></name><xref ref-type="aff" rid="aff18">18</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Senger</surname><given-names>Roberta</given-names></name><xref ref-type="aff" rid="aff18">18</xref><role>RN</role></contrib><contrib contrib-type="author"><name><surname>Buffolo</surname><given-names>Enio</given-names></name><xref ref-type="aff" rid="aff19">19</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Caputi</surname><given-names>Guido Marco</given-names></name><xref ref-type="aff" rid="aff19">19</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>de Oliveira</surname><given-names>Juliana Aparecida Borges</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>RN</role></contrib><contrib contrib-type="author"><name><surname>Gomes</surname><given-names>Walter J.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, MSc, PhD</role></contrib><contrib contrib-type="author"><collab>BYPASS Registry Study Group</collab></contrib></contrib-group><aff id="aff1">
<label>1</label> Hospital S&#x000e3;o Paulo, Escola Paulista de Medicina da
Universidade Federal de S&#x000e3;o Paulo, (EPM - UNIFESP), S&#x000e3;o Paulo, SP,
Brazil.</aff><aff id="aff2">
<label>2</label> Instituto de Pesquisa do Hospital do Cora&#x000e7;&#x000e3;o (IP -
HCor), S&#x000e3;o Paulo, SP, Brazil.</aff><aff id="aff3">
<label>3</label> Instituto de Cardiologia do Rio Grande do Sul -
Funda&#x000e7;&#x000e3;o Universit&#x000e1;ria de Cardiologia, Porto Alegre, RS,
Brazil.</aff><aff id="aff4">
<label>4</label> Cardiovascular Surgery Division, Instituto do Cora&#x000e7;&#x000e3;o
do Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de
S&#x000e3;o Paulo (InCor-HCFMUSP), S&#x000e3;o Paulo, SP, Brazil.</aff><aff id="aff5">
<label>5</label> Hospital de Caridade S&#x000e3;o Vicente de Paulo, Jundia&#x000ed;,
SP, Brazil.</aff><aff id="aff6">
<label>6</label> Instituto de Medicina Integral Professor Fernando Figueira (IMIP),
Recife, PE, Brazil.</aff><aff id="aff7">
<label>7</label> Hospital de Base - FUNFARME e FAMERP, S&#x000e3;o Jos&#x000e9; do Rio
Preto, SP, Brazil.</aff><aff id="aff8">
<label>8</label> Instituto de Mol&#x000e9;stias Cardiovasculares (IMC), S&#x000e3;o
Jos&#x000e9; do Rio Preto, SP, Brazil.</aff><aff id="aff9">
<label>9</label> Irmandade da Santa Casa de S&#x000e3;o Paulo (INCT-HPV/Faculdade de
Ci&#x000ea;ncias M&#x000e9;dicas da Santa Casa de S&#x000e3;o Paulo), S&#x000e3;o Paulo,
SP, Brazil</aff><aff id="aff10">
<label>10</label> Instituto do Cora&#x000e7;&#x000e3;o de Natal, Natal, RN,
Brazil.</aff><aff id="aff11">
<label>11</label> Instituto de Cardiologia do Distrito Federal, Bras&#x000ed;lia, DF,
Brazil.</aff><aff id="aff12">
<label>12</label> Hospital Universit&#x000e1;rio da Universidade Federal do
Maranh&#x000e3;o (HU/UFMA), S&#x000e3;o Lu&#x000ed;s, MA, Brazil.</aff><aff id="aff13">
<label>13</label> Hospital Evang&#x000e9;lico, Cachoeiro de Itapemirim, ES,
Brazil.</aff><aff id="aff14">
<label>14</label> Hospital do Cora&#x000e7;&#x000e3;o de Sergipe, Aracaju, SE,
Brazil.</aff><aff id="aff15">
<label>15</label> Instituto de Cirurgia Cardiovascular (ICCV)/Hospital Nossa Senhora
da Salete, Cascavel, PR, Brazil.</aff><aff id="aff16">
<label>16</label> Hospital Wilson Rosado, Mossor&#x000f3;, RN, Brazil.</aff><aff id="aff17">
<label>17</label> Hospital Bosque da Sa&#x000fa;de, S&#x000e3;o Paulo, SP,
Brazil.</aff><aff id="aff18">
<label>18</label> Hospital Universit&#x000e1;rio de Santa Maria, Santa Maria, RS,
Brazil.</aff><aff id="aff19">
<label>19</label> Hospital do Cora&#x000e7;&#x000e3;o (HCor), S&#x000e3;o Paulo, SP,
Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: <bold>Rodrigo Pereira Paez</bold>,
https://orcid.org/0000-0001-5860-901X, Avenida Ira&#x000ed;, 2104 - S&#x000e3;o
Paulo, SP, Brazil - Zip code: 04082-006. E-mail:
<email>rppaez@me.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2019</year></pub-date><volume>34</volume><issue>2</issue><fpage>142</fpage><lpage>148</lpage><history><date date-type="received"><day>02</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>27</day><month>1</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Coronary artery bypass grafting (CABG) is the most frequently performed heart
surgery in Brazil. Recent international guidelines recommend that national
societies establish a database on the practice and results of CABG. In
anticipation of the recommendation, the BYPASS Registry was introduced in
2015.</p></sec><sec><title>Objective</title><p>To analyze the profile, risk factors and outcomes of patients undergoing CABG
in Brazil, as well as to examine the predominant surgical strategy, based on
the data included in the BYPASS Registry.</p></sec><sec><title>Methods</title><p>A cross-sectional study of 2292 patients undergoing CABG surgery and
cataloged in the BYPASS Registry up to November 2018. Demographic data,
clinical presentation, operative variables, and postoperative hospital
outcomes were analyzed.</p></sec><sec><title>Results</title><p>Patients referred to CABG in Brazil are predominantly male (71%), with prior
myocardial infarction in 41.1% of cases, diabetes in 42.5%, and ejection
fraction lower than 40% in 9.7%. The Heart Team indicated surgery in 32.9%
of the cases. Most of the patients underwent cardiopulmonary bypass (87%),
and cardioplegia was the strategy of myocardial protection chosen in 95.2%
of the cases. The left internal thoracic artery was used as a graft in 91%
of the cases; the right internal thoracic artery, in 5.6%; and the radial
artery in 1.1%. The saphenous vein graft was used in 84.1% of the patients,
being the only graft employed in 7.7% of the patients. The median number of
coronary vessels treated was 3. Operative mortality was 2.8%, and the
incidence of cerebrovascular accident was 1.2%.</p></sec><sec><title>Conclusion</title><p>CABG data in Brazil provided by the BYPASS Registry analysis are
representative of our national reality and practice. This database
constitutes an important reference for indications and comparisons of
therapeutic procedures, as well as to propose subsequent models to improve
patient safety and the quality of surgical practice in the country.</p></sec></abstract><kwd-group><kwd>Registries</kwd><kwd>Database, Cardiovascular Surgical Procedures</kwd><kwd>Cardiac Surgical Procedures</kwd><kwd>Coronary Artery Bypass Grafts</kwd><kwd>Myocardial Revascularization</kwd></kwd-group></article-meta></front><body><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="42%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="42%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ADA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Anterior descending
artery</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">GCP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Good Clinical
Practices</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ARDS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Adult respiratory
distress syndrome</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ITA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Internal thoracic
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BYPASS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Brazilian Registry of
Adult Patients UndergoingCardiovascular Surgery</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LAD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left anterior
descending</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LITA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left internal thoracic
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CAD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery
disease</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LVEF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left ventricular
ejection fraction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">COPD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Chronic obstructive
pulmonary disease</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Myocardial
infarction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NYHA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= New York Heart
Association classification for heart&#x000a0;failure</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EACTS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European Association for
Cardio-Thoracic Surgery</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PCI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Percutaneous coronary
intervention</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EAPC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European Association of
Percutaneous Cardiovascular&#x000a0;Interventions</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RITA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Right internal thoracic
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ESC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European Society of
Cardiology</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SBCCV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Sociedade Brasileira de
Cirurgia Cardiovascular</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">FREEDOM</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Future Revascularization
Evaluation in Patients withDiabetes Mellitus: Optimal Management of
Multivessel Disease</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">STS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Society of Thoracic
Surgeons</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SVG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Saphenous vein
grafts</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SYNTAX</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Synergy Between
Percutaneous Coronary Intervention&#x000a0;with TAXUS and Cardiac Surgery</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>The Brazilian Registry of Adult Patients Undergoing Cardiovascular Surgery - the
BYPASS Project - is an ongoing database established in 2015 by the Sociedade
Brasileira de Cirurgia Cardiovascular (SBCCV) and aimed to collect perioperative and
postoperative data from patients undergoing cardiac surgery in Brazil.</p><p>The first report of the BYPASS revealed that coronary artery bypass grafting (CABG)
is the most frequently performed cardiac surgery in Brazil, encompassing 54.1% of
the cases<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. CABG remains the
standard of care for management of patients with coronary artery disease,
particularly in high-risk patients with multivessel disease, diabetics, aged 65
years or more, with left main stem or with impaired left ventricular function.</p><p>Previous analyses of results of CABG patients in Brazil were derived from single
centers, a group of hospitals or defective databases, failing to reach national
representativeness. Recent international guidelines recommend that national
societies establish their own database on the practice and results of CABG and, in
anticipation of this, the BYPASS registry was introduced in 2015<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>To provide a comprehensive understanding of the scenario of cardiovascular surgery in
Brazil, this analysis presents the clinical profile and outcomes of patients
undergoing CABG and enrolled in the BYPASS project, assessing the data harvested
from the initial cohort of patients included.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This study was approved by the Research Ethics Committee of the Universidade Federal
de S&#x000e3;o Paulo (UNIFESP - Registration number 1143/2017) and compiled data from
the Bypass Registry, an observational and prospective study, with longitudinal
follow-up. This report comprises a cross-sectional study, evaluating patients
undergoing first-time isolated CABG.</p><p>Population and Locations</p><p>The participation of cardiovascular centers in this project was voluntary and
involved 17 institutions throughout the country and located in the following
regions: Southeast<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>,
Northeast<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>,
South<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, and
Central-West<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.</p><p>The project is partnered with the HCor Research Institute, responsible for
collecting, analyzing and auditing the data.</p><p>A total of 2292 patients were analyzed, included until November 2018. The population
consisted of patients older than 18 years of age, submitted to first-time isolated
CABG, without other associated procedures. The informed consent form was signed by
every patient included in the study and the data collection followed the National
Clinical Research regulation standards as well as the Document of the Americas and
Good Clinical Practice (GCP). The Bypass Registry was approved by the Ethics and
Research Committee of the coordinating center and each participating
institution.</p><sec><title>Profile and Outcomes</title><p>The main variables assessed were demographic data, clinical presentation, risk
factors, medications in use, left ventricular ejection fraction (LVEF),
evaluated by echocardiography, and laboratory tests. Intraoperative data
recorded operative time, use of cardiopulmonary bypass (CPB) and cardioplegia,
type of grafts harvested, and preferred anastomotic techniques (direct,
sequential or Y-composite grafts). Postoperative data included incidence of the
following complications: stroke, major bleeding requiring reoperation,
utilization of blood products, vasoplegia, arrhythmia, myocardial infarction,
low cardiac output, use of vasoactive drugs, mechanical ventilation longer than
24 hours, kidney failure, need for transfusion, infection, and hospital
mortality.</p></sec><sec><title>Statistical Analysis</title><p>The quantitative variables were described by mean &#x000b1; standard deviation,
and the qualitative variables were presented in form of absolute and relative
frequency. Statistical analyses were performed with the Statistical Package R
version 3.3.2 (R Foundation for Statistical Computing).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Epidemiological data and relative risk factors for heart disease are presented in
<xref rid="t1" ref-type="table">Table 1</xref>. Patients referred to CABG in
Brazil were predominantly male (71%), mean age 63.5&#x000b1;9.6 years, with recent
myocardial infarction (MI) in 41.1% of the cases.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographics data.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Total (n=2292)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Sex (female)</td><td align="center" rowspan="1" colspan="1">665/2292 (29%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Age; mean&#x000b1;SD (years)</td><td align="center" rowspan="1" colspan="1">63.5&#x000b1;9.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Family history</td><td align="center" rowspan="1" colspan="1">867/2292 (37.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1">973/2292 (42.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Dyslipidemia</td><td align="center" rowspan="1" colspan="1">1250/2292 (54.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">1937/2292 (84.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Infarction</td><td align="center" rowspan="1" colspan="1">941/2292 (41.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous PCI</td><td align="center" rowspan="1" colspan="1">289/2292 (12.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous heart surgery</td><td align="center" rowspan="1" colspan="1">48/2292 (2.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">CVA</td><td align="center" rowspan="1" colspan="1">93/2292 (4.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">PAD</td><td align="center" rowspan="1" colspan="1">170/2292 (7.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart failure</td><td align="center" rowspan="1" colspan="1">328/2292 (14.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA (1)</td><td align="center" rowspan="1" colspan="1">42/312 (13.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA (2)</td><td align="center" rowspan="1" colspan="1">181/312 (58%)</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA (3)</td><td align="center" rowspan="1" colspan="1">82/312 (26.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA (4)</td><td align="center" rowspan="1" colspan="1">7/312 (2.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Kidney failure</td><td align="center" rowspan="1" colspan="1">111/2292 (4.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Dialysis</td><td align="center" rowspan="1" colspan="1">18/109 (16.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiac arrest</td><td align="center" rowspan="1" colspan="1">45/2292 (2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Current smoker</td><td align="center" rowspan="1" colspan="1">309/2292 (13.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ex-smoker</td><td align="center" rowspan="1" colspan="1">570/2286 (24.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Arrhythmia</td><td align="center" rowspan="1" colspan="1">117/2292 (5.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Pacemaker</td><td align="center" rowspan="1" colspan="1">20/2292 (0.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">COPD</td><td align="center" rowspan="1" colspan="1">128/2292 (5.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">EF &#x0003c;40%</td><td align="center" rowspan="1" colspan="1">185/1904 (9.7%)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>COPD=chronic obstructive pulmonary disease; CVA=cerebrovascular accident;
EF=ejection fraction; NYHA=New York Heart Association classification for
heart failure; PAD=peripheral artery disease; PCI=percutaneous coronary
intervention</p></fn></table-wrap-foot></table-wrap><p><xref rid="t2" ref-type="table">Table 2</xref> depicts the reimbursement source,
whether public or private, and the setting in which the patients were operated on;
<italic>i.e</italic>., elective or urgent surgery. Most of the patients were
admitted through the public healthcare system (84.4%) and operated under elective
conditions (77.7%).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Reimbursement source and preoperative conditions.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Total (n=2292)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Reimbursement source</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Public healthcare system</td><td align="center" rowspan="1" colspan="1">1934/2292 (84.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Private - Health insurance</td><td align="center" rowspan="1" colspan="1">358/2292 (15.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Type of procedure</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Elective surgery</td><td align="center" rowspan="1" colspan="1">1781/2292 (77.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Urgent surgery</td><td align="center" rowspan="1" colspan="1">478/2292 (20.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Emergency surgery</td><td align="center" rowspan="1" colspan="1">32/2292 (1.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Surgery indicated by the Heart Team</td><td align="center" rowspan="1" colspan="1">754/2292 (32.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Clinical conditions</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Stable</td><td align="center" rowspan="1" colspan="1">2212/2292 (96.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Unstable</td><td align="center" rowspan="1" colspan="1">73/2292 (3.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Critical</td><td align="center" rowspan="1" colspan="1">7/2292 (0.3%)</td></tr></tbody></table></table-wrap><p>Intraoperative variables regarding surgical access, use of cardiopulmonary bypass,
myocardial protection, use of internal thoracic artery and other arterial grafts, Y-
or sequential grafts were collected according to <xref rid="t3" ref-type="table">Table 3</xref>.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Intraoperative characteristics.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Total (n=2292)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Open-heart surgery</td><td align="center" rowspan="1" colspan="1">2291/2292 (100%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Minimally invasive surgery</td><td align="center" rowspan="1" colspan="1">1/2292 (0%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of cardiopulmonary bypass</td><td align="center" rowspan="1" colspan="1">1994/2292 (87%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardioplegia</td><td align="center" rowspan="1" colspan="1">1899/1994 (95.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Grafts</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">SVG</td><td align="center" rowspan="1" colspan="1">1925/2289 (84.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">No SVG (only arterial grafts)</td><td align="center" rowspan="1" colspan="1">364/2289 (15.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Only SVG</td><td align="center" rowspan="1" colspan="1">176/2289 (7.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of LITA</td><td align="center" rowspan="1" colspan="1">2083/2289 (91%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of RITA</td><td align="center" rowspan="1" colspan="1">129/2289 (5.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">One ITA</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of LITA or RITA</td><td align="center" rowspan="1" colspan="1">1994/2289 (87.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of Only LITA or RITA</td><td align="center" rowspan="1" colspan="1">300/2289 (13.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Two ITA</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of LITA and RITA</td><td align="center" rowspan="1" colspan="1">109/2289 (4.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of Only LITA and RITA</td><td align="center" rowspan="1" colspan="1">48/2289 (2.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of radial artery</td><td align="center" rowspan="1" colspan="1">25/2289 (1.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Treated vessels; median [quartiles]</td><td align="center" rowspan="1" colspan="1">3 [2 - 4] (n=2292)</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>ITA=internal thoracic artery; LITA=left internal thoracic artery;
RITA=right internal thoracic artery; SVG=saphenous vein graft</p></fn></table-wrap-foot></table-wrap><p>Intraoperative clinical events, such as bleeding, vasoplegia, arrhythmias, infarction
[defined as an elevation of more than 10 times the upper limit of troponin T], use
of vasopressors and intraoperative death are shown in <xref rid="t4" ref-type="table">Table 4</xref>. Postoperative follow-up was also analyzed in view of
the main indicators and complications that may occur, according to <xref rid="t5" ref-type="table">Table 5</xref>.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Intraoperative complications.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Total (n=2292)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Myocardial infarction</td><td align="center" rowspan="1" colspan="1">11/2292 (0.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Major bleeding</td><td align="center" rowspan="1" colspan="1">119/2292 (5.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Transfusion</td><td align="center" rowspan="1" colspan="1">539/2292 (23.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Postperfusion syndrome</td><td align="center" rowspan="1" colspan="1">15/2292 (0.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Arrhythmia</td><td align="center" rowspan="1" colspan="1">70/2292 (3.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Low cardiac output</td><td align="center" rowspan="1" colspan="1">102/2292 (4.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of vasoconstrictors</td><td align="center" rowspan="1" colspan="1">1137/2292 (49.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Intraoperative death</td><td align="center" rowspan="1" colspan="1">12/2292 (0.5%)</td></tr></tbody></table></table-wrap><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Postoperative intra-hospital data.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Total (n=2292)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Reoperation</td><td align="center" rowspan="1" colspan="1">52/2280 (2.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Major bleeding</td><td align="center" rowspan="1" colspan="1">62/2280 (2.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">PCI</td><td align="center" rowspan="1" colspan="1">5/2280 (0.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mechanical ventilation more than 24h</td><td align="center" rowspan="1" colspan="1">120/2280 (5.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tracheostomy</td><td align="center" rowspan="1" colspan="1">12/2280 (0.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">ARDS</td><td align="center" rowspan="1" colspan="1">33/2280 (1.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Low cardiac output</td><td align="center" rowspan="1" colspan="1">73/2280 (3.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Kidney failure</td><td align="center" rowspan="1" colspan="1">84/2280 (3.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Dialysis</td><td align="center" rowspan="1" colspan="1">30/84 (35.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Coagulopathy</td><td align="center" rowspan="1" colspan="1">23/2280 (1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Transfusion</td><td align="center" rowspan="1" colspan="1">446/2280 (19.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Arrythmias</td><td align="center" rowspan="1" colspan="1">336/2280 (14.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Need for pacemaker</td><td align="center" rowspan="1" colspan="1">91/2280 (4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Infection</td><td align="center" rowspan="1" colspan="1">118/2280 (5.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial infarction</td><td align="center" rowspan="1" colspan="1">27/2280 (1.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Vasoplegic syndrome</td><td align="center" rowspan="1" colspan="1">27/2280 (1.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Death</td><td align="center" rowspan="1" colspan="1">64/2292 (2.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart failure</td><td align="center" rowspan="1" colspan="1">29/2280 (1.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">CVA</td><td align="center" rowspan="1" colspan="1">28/2280 (1.2%)</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>ARDS=adult respiratory distress syndrome; CVA=cardiovascular accident;
PCI=percutaneous coronary intervention</p></fn></table-wrap-foot></table-wrap><p>Most of the patients underwent CPB (87%), and cardioplegia was the strategy of
myocardial protection chosen in 95.2% of the cases.</p><p>The left internal thoracic artery (LITA) was used in 91% of the cases; the right
internal thoracic artery (RITA), in 5.6%; and radial artery in only 1.1%. Total
arterial revascularization was performed in 15.9%, and a significant portion (13.1%,
300 of 2289 patients) received an isolated internal thoracic artery graft to the
left anterior descending (LAD) artery.</p><p>Saphenous vein grafts (SVG) were used in up to 84.1% of patients. There were 7.7% of
patients revascularized with vein grafts only, without arterial grafts. The median
number of vessels treated was 3<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>The in-hospital mortality rate was 2.8%, and the incidence of clinically relevant
cerebrovascular accident was 1.2%.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Coronary artery disease is one of the leading causes of mortality and morbidity in
the 21<sup>st</sup> century<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. In
Brazil, approximately 30% of people die from cardiovascular causes according to data
from the Unified Health System (DATASUS)<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>In 2014, CABG celebrated six decades since Kolesov's direct coronary approach for
myocardial revascularization. And the technique continues to evolve at all times,
from the onset of the worldwide experience without CPB, to the advent of CPB,
returning to new scenarios without the use of CPB<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>; from the use of the saphenous vein to the use of
the internal thoracic artery, including sequential anastomoses, until coronary
artery bypass grafting completely performed with arterial grafts<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>, with graft quality control by
Doppler graft flow measurement<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>In patients with stable chronic disease, CABG is indicated to relieve symptoms and/or
improve prognosis<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. CABG surgery
has well established indications and benefits when it comes to left main artery
disease, multivessel coronary artery disease, diabetes, proximal LAD occlusion and
left ventricular dysfunction<sup>[<xref rid="r9" ref-type="bibr">9</xref>-<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p><p>In recent decades, hospitals and surgeons have been called upon to present their
findings to the medical community and society. The European EuroSCORE study showed
general mortality in cardiac surgery around 3.1%, while the American multicenter
Society of Thoracic Surgeons (STS), around 2.0%<sup>[<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r14" ref-type="bibr">14</xref>]</sup>. Hannan et
al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>, analyzing 49,830
patients undergoing CABG surgery in New York state between 2001 and 2004, found
mortality around 1.19%, stroke around 1.2%, transmural infarction 0.5% sternal
infection 0.9%, reoperation for bleeding 1.9%, sepsis 1.0%, renal dialysis 1.4%,
respiratory failure 3.7%, and reoperation 1.2%.</p><p>In our country, Silva et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>
showed an operative mortality rate of 4.0% in patients operated by the Unified
Health System (SUS) at the Hospital Benefic&#x000ea;ncia Portuguesa in S&#x000e3;o
Paulo, while Fortes et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref>]</sup> showed an average mortality of
7.4% in patients referred for CABG in a university hospital in northeastern Brazil.
TotalCor Hospital, a private hospital focused on cardiology, points to a mortality
rate of 1.7%. The profile of the patient operated in this private hospital is also
favorable, with an expected mortality rate of 0.7%<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>.</p><p>The BYPASS Registry is the first study of a Brazilian multicenter database with
national representativity. The records strengthen that Brazilian patients, in
general, have little access to primary prevention and surgery was indicated after
heart attacks, heart failure and ventricular dysfunction. Brazilian patients have
unsatisfactory outpatient follow-up and are generally poorly medicated, either due
to poor adherence or lack of medication in the public healthcare system.</p><p>Since it is a voluntary participation, currently 17 Brazilian centers spontaneously
provide their data to the BYPASS Registry. It should be remembered that the STS
database also started with few centers and still does not reach all centers yet, but
around 90%. Over the years, the participation of centers increased due to the
benefits of having their results analyzed and receiving advice to improve hospital
processes focused on surgical quality and patient safety. Currently, the STS
participating center is a recognized center for quality control and continuous
improvement. The TotalCor Hospital in S&#x000e3;o Paulo provides data for the STS
since 2011 and has since reached a decrease in the time of mechanical ventilation
and hospital stay through the guidelines received<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. Since its first publication in 2018, the BYPASS
study has had great adherence of cardiac surgeons, increasing from 945 to 2292
patients undergoing CABG in follow-up. The BYPASS study also seeks to be an
evaluator and consultant in the process of improvement in cardiovascular surgery in
Brazil.</p><p>Diabetes was more prevalent in patients undergoing revascularization in Brazil, when
compared to other international registries, such as the SYNTAX (Synergy Between
Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) trial<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. FREEDOM (Future
Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management
of Multivessel Disease) trial defined bypass surgery as the standard treatment for
diabetic and multivessel patients, mainly directing these patients for surgery.</p><p>Less than one-third of the reported patients undergoing revascularization surgery
were female. Approximately 12% of the patients who underwent surgery had previously
undergone percutaneous coronary interventions, an issue that deserves further
investigation regarding the quality of the revascularization provided to these
patients.</p><p>The vast majority of patients (84.4%) were operated in the public healthcare system,
which draws attention since approximately 30% of Brazilians have private health
insurance<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. Such
information suggests that many patients with access to private health care are
operated on public hospitals, or that patients who have access to private health
care initially avoid being referred to surgery.</p><p>The analysis showed that operative mortality in CABG in Brazil was slightly higher
compared to North American and European centers. This finding is remarkable, given
the limited budget, resources and infrastructure of the health system, both private
and public, as well as operating rooms and intensive care units, both in basic
equipment and human resources.</p><p>Brazilian surgeons currently prefer to perform on-pump CABG, the technique employed
in 87% of the cases. In this scenario, cardioplegia has been the preferred strategy
for myocardial protection (95.2%). This is an amazing finding in a country that
pioneered the development of off-pump coronary surgery. Minimally invasive or
robotic revascularization is not routinely performed in Brazil.</p><p>Major complications such as death, cerebrovascular accident, and myocardial
infarction were similar to those of international studies. Major bleeding requiring
reoperation, arrhythmias, kidney failure, infection and heart failure were also
similar.</p><p>Vasoplegia was uncommon (0.7%) in this study. It is a well-known complication in the
postoperative period of cardiovascular surgery, defined by hemodynamic collapse
similar to septic shock, characterized by decreased systemic vascular resistance,
increased cardiac index and severe hypotension, despite the use of vasoactive drugs,
occurring in the first postoperative hours<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>.</p><p>The use of sequential anastomoses is a strategy to minimize aortic manipulation, but
also to reduce CPB time and aortic cross-clamping.</p><p>Bilateral internal thoracic arteries (ITA) were used only in 4.8% of the patients, a
practice more frequent than that reported by the STS database (4.1%), but fair below
the European practice (10%)<sup>[<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref>]</sup>. Only 16.9% of the patients had
total arterial graft, of which 69% of the patients received only one ITA graft.</p><p>The radial artery was seldom used (1.1%); and 7.7% of the patients received only the
saphenous vein as a graft. The saphenous vein graft was widely used (84.1%), similar
to Europe (84.4%) and the United States (95.1%)<sup><xref rid="r22" ref-type="bibr">22</xref>-<xref rid="r24" ref-type="bibr">24</xref></sup>. The time spent
for preparation of the grafts can influence surgical teams with high volume to
prefer the saphenous vein use instead of harvesting the second internal thoracic
artery. Injury of the LITA during the preparation may also induce the surgeon to
perform saphenous surgery instead of preparing the RITA.</p><p>Only 32.9% of the patients had their procedures indicated by the Heart Team, being a
growing trend and demands of medical guidelines that patients have indication for
cardiac procedures discussed and based on scientific evidence. Since the first
report, the BYPASS study has seen a large increase in the participation of the Heart
Team in the indication of cardiac surgeries<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.</p><p>Understanding the differences between the surgical strategy of the Brazilian surgeon
and that of other countries, even with regional differences, may guide and suggest
improvements in the routines adopted by different centers<sup>[<xref rid="r25" ref-type="bibr">25</xref>,<xref rid="r26" ref-type="bibr">26</xref>]</sup>.</p><p>The experience of international databases shows that its continuous data management
brings long-term benefits, optimizing hospital practices and directing preventive
policies. The dissemination of the BYPASS Registry and the invitation to surgeons to
provide their data have contributed to the growth of the database. The adherence of
several Brazilian centers to provide their data to the BYPASS Registry should be
encouraged as part of a process of continuous medical improvement and patient
safety. Policies should be designed to help fund national registries and stimulate
surgeons to provide their data.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>The CABG data in Brazil provided by the BYPASS Registry analysis are, so far, the
most representative of our national reality and practice. This database constitutes
an important reference for indications and comparisons of therapeutic procedures, as
well as to propose subsequent models to improve patient safety and the quality of
surgical practice in the country.</p><table-wrap id="t7" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">WJG, JAES, JABO, OB, ABC, FBJ</td><td align="left" rowspan="1" colspan="1">Conception and study design; data management;
manuscript redaction or critical review of its content; final
manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">Other authors</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Universidade Federal de S&#x000e3;o Paulo
(UNIFESP/EPM), S&#x000e3;o Paulo, SP, Brazil.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>WJ</given-names></name><name><surname>Moreira</surname><given-names>RS</given-names></name><name><surname>Zilli</surname><given-names>AC</given-names></name><name><surname>Bettiati Jr.</surname><given-names>LC</given-names></name><name><surname>Figueira</surname><given-names>F</given-names></name><collab>SSP DA</collab><etal/></person-group><article-title>The Brazilian Registry of Adult Patient Undergoing Cardiovascular
Surgery, the BYPASS Project: Results of the First 1,722
Patients</article-title><source>Braz J Cardiovasc Surg</source><year>2017</year><volume>32</volume><issue>2</issue><fpage>71</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.21470/1678-9741-2017-0053</pub-id><pub-id pub-id-type="pmid">28492786</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sousa-Uva</surname><given-names>M</given-names></name><name><surname>Neumann</surname><given-names>FJ</given-names></name><name><surname>Ahlsson</surname><given-names>A</given-names></name><name><surname>Alfonso</surname><given-names>F</given-names></name><name><surname>Banning</surname><given-names>AP</given-names></name><name><surname>Benedetto</surname><given-names>U</given-names></name><etal/></person-group><article-title>2018 ESC/EACTS Guidelines on myocardial
revascularization</article-title><source>Eur J Cardiothorac Surg</source><year>2019</year><volume>55</volume><issue>1</issue><fpage>4</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezy289</pub-id><pub-id pub-id-type="pmid">30165632</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thygesen</surname><given-names>K</given-names></name><name><surname>Alpert</surname><given-names>JS</given-names></name><name><surname>Jaffe</surname><given-names>AS</given-names></name><name><surname>Chaitman</surname><given-names>BR</given-names></name><name><surname>Bax</surname><given-names>JJ</given-names></name><name><surname>Morrow</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Fourth universal definition of myocardial infarction
(2018)</article-title><source>Eur Heart J</source><year>2019</year><volume>40</volume><issue>3</issue><fpage>237</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehy462</pub-id><pub-id pub-id-type="pmid">30165617</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>MW</given-names></name><name><surname>Kaplan</surname><given-names>E</given-names></name><name><surname>Hermanides</surname><given-names>RS</given-names></name><name><surname>Fabris</surname><given-names>E</given-names></name><name><surname>Hemradj</surname><given-names>V</given-names></name><name><surname>Koopmans</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Clinical outcomes of deferred revascularisation using fractional
flow reserve in patients with and without diabetes mellitus</article-title><source>Cardiovasc Diabetol</source><year>2016</year><volume>15</volume><fpage>100</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1186/s12933-016-0417-2</pub-id><pub-id pub-id-type="pmid">27431395</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansur Ade</surname><given-names>P</given-names></name><name><surname>Favarato</surname><given-names>D</given-names></name></person-group><article-title>Mortality due to cardiovascular diseases in Brazil and in the
metropolitan region of S&#x000e3;o Paulo: a 2011 update</article-title><source>Arq Bras Cardiol</source><year>2012</year><volume>99</volume><issue>2</issue><fpage>755</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1590/S0066-782X2012005000061</pub-id><pub-id pub-id-type="pmid">22735870</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffolo</surname><given-names>E</given-names></name><name><surname>Andrade</surname><given-names>JC</given-names></name><name><surname>Succi</surname><given-names>JE</given-names></name><name><surname>Leao</surname><given-names>LE</given-names></name><name><surname>Cueva</surname><given-names>C</given-names></name><name><surname>Branco</surname><given-names>JN</given-names></name><etal/></person-group><article-title>Direct myocardial revascularization without extracorporeal
circulation: technique and initial results</article-title><source>Tex Heart Inst J</source><year>1985</year><volume>12</volume><issue>1</issue><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">15227039</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calafiore</surname><given-names>AM</given-names></name><name><surname>Teodori</surname><given-names>G</given-names></name><name><surname>Di Giammarco</surname><given-names>G</given-names></name><name><surname>Vitolla</surname><given-names>G</given-names></name><name><surname>Maddestra</surname><given-names>N</given-names></name><name><surname>Paloscia</surname><given-names>L</given-names></name><etal/></person-group><article-title>Multiple arterial conduits without cardiopulmonary bypass: early
angiographic results</article-title><source>Ann Thorac Surg</source><year>1999</year><volume>67</volume><issue>2</issue><fpage>450</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">10197669</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolh</surname><given-names>P</given-names></name><name><surname>Windecker</surname><given-names>S</given-names></name><name><surname>Alfonso</surname><given-names>F</given-names></name><name><surname>Collet</surname><given-names>JP</given-names></name><name><surname>Cremer</surname><given-names>J</given-names></name><name><surname>Falk</surname><given-names>V</given-names></name><etal/></person-group><article-title>2014 ESC/EACTS Guidelines on myocardial revascularization: the
Task Force on Myocardial Revascularization of the European Society of
Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery
(EACTS). Developed with the special contribution of the European Association
of Percutaneous Cardiovascular Interventions (EAPCI)</article-title><source>Eur J Cardiothorac Surg</source><year>2014</year><volume>46</volume><issue>4</issue><fpage>517</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezu366</pub-id><pub-id pub-id-type="pmid">25173601</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hueb</surname><given-names>W</given-names></name><name><surname>Lopes</surname><given-names>N</given-names></name><name><surname>Gersh</surname><given-names>BJ</given-names></name><name><surname>Soares</surname><given-names>PR</given-names></name><name><surname>Ribeiro</surname><given-names>EE</given-names></name><name><surname>Pereira</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Ten-year follow-up survival of the Medicine, Angioplasty, or
Surgery Study (MASS II): a randomized controlled clinical trial of 3
therapeutic strategies for multivessel coronary artery
disease</article-title><source>Circulation</source><year>2010</year><volume>122</volume><issue>10</issue><fpage>949</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1161/circulationaha.109.911669</pub-id><pub-id pub-id-type="pmid">20733102</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yusuf</surname><given-names>S</given-names></name><name><surname>Zucker</surname><given-names>D</given-names></name><name><surname>Peduzzi</surname><given-names>P</given-names></name><name><surname>Fisher</surname><given-names>LD</given-names></name><name><surname>Takaro</surname><given-names>T</given-names></name><name><surname>Kennedy</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Effect of coronary artery bypass graft surgery on survival:
overview of 10-year results from randomised trials by the Coronary Artery
Bypass Graft Surgery Trialists Collaboration</article-title><source>Lancet</source><year>1994</year><volume>344</volume><issue>8922</issue><fpage>563</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">7914958</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serruys</surname><given-names>PW</given-names></name><name><surname>Morice</surname><given-names>MC</given-names></name><name><surname>Kappetein</surname><given-names>AP</given-names></name><name><surname>Colombo</surname><given-names>A</given-names></name><name><surname>Holmes</surname><given-names>DR</given-names></name><name><surname>Mack</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Percutaneous coronary intervention versus coronary-artery bypass
grafting for severe coronary artery disease</article-title><source>N Engl J Med</source><year>2009</year><volume>360</volume><issue>10</issue><fpage>961</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0804626</pub-id><pub-id pub-id-type="pmid">19228612</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapoor</surname><given-names>JR</given-names></name><name><surname>Gienger</surname><given-names>AL</given-names></name><name><surname>Ardehali</surname><given-names>R</given-names></name><name><surname>Varghese</surname><given-names>R</given-names></name><name><surname>Perez</surname><given-names>MV</given-names></name><name><surname>Sundaram</surname><given-names>V</given-names></name><etal/></person-group><article-title>Isolated disease of the proximal left anterior descending artery
comparing the effectiveness of percutaneous coronary interventions and
coronary artery bypass surgery</article-title><source>JACC Cardiovasc Interv</source><year>2008</year><volume>1</volume><issue>5</issue><fpage>483</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1016/j.jcin.2008.07.001</pub-id><pub-id pub-id-type="pmid">19463349</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>SW</given-names></name><name><surname>Hickey</surname><given-names>GL</given-names></name><name><surname>Dimarakis</surname><given-names>I</given-names></name><name><surname>Trivedi</surname><given-names>U</given-names></name><name><surname>Bryan</surname><given-names>A</given-names></name><name><surname>Treasure</surname><given-names>T</given-names></name><etal/></person-group><article-title>How does EuroSCORE II perform in UK cardiac surgery; an analysis
of 23 740 patients from the Society for Cardiothoracic Surgery in Great
Britain and Ireland National Database</article-title><source>Heart</source><year>2012</year><volume>98</volume><issue>21</issue><fpage>1568</fpage><lpage>1572</lpage><pub-id pub-id-type="doi">10.1136/heartjnl-2012-302483</pub-id><pub-id pub-id-type="pmid">22914533</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>JP</given-names></name><name><surname>Shahian</surname><given-names>DM</given-names></name><name><surname>Prager</surname><given-names>RL</given-names></name><name><surname>Edwards</surname><given-names>FH</given-names></name><name><surname>McDonald</surname><given-names>D</given-names></name><name><surname>Han</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Introduction to the STS National Database Series: Outcomes
Analysis, Quality Improvement, and Patient Safety</article-title><source>Ann Thorac Surg</source><year>2015</year><volume>100</volume><issue>6</issue><fpage>1992</fpage><lpage>2000</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2015.10.060</pub-id><pub-id pub-id-type="pmid">26525868</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannan</surname><given-names>EL</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>CR</given-names></name><name><surname>Higgins</surname><given-names>RS</given-names></name><name><surname>Carlson</surname><given-names>RE</given-names></name><name><surname>Culliford</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Off-pump versus on-pump coronary artery bypass graft surgery:
differences in short-term outcomes and in long-term mortality and need for
subsequent revascularization</article-title><source>Circulation</source><year>2007</year><volume>116</volume><issue>10</issue><fpage>1145</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1161/circulationaha.106.675595</pub-id><pub-id pub-id-type="pmid">17709642</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>GSD</given-names></name><name><surname>Colosimo</surname><given-names>FC</given-names></name><name><surname>Sousa</surname><given-names>AG</given-names></name><name><surname>Piotto</surname><given-names>RF</given-names></name><name><surname>Castilho</surname><given-names>V</given-names></name></person-group><article-title>Coronary Artery Bypass Graft Surgery Cost Coverage by the
Brazilian Unified Health System (SUS)</article-title><source>Braz J Cardiovasc Surg</source><year>2017</year><volume>32</volume><issue>4</issue><fpage>253</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.21470/1678-9741-2016-0069</pub-id><pub-id pub-id-type="pmid">28977196</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortes</surname><given-names>JV</given-names></name><name><surname>Barbosa e Silva</surname><given-names>MG</given-names></name><name><surname>Baldez</surname><given-names>TE</given-names></name><name><surname>Costa</surname><given-names>MA</given-names></name><name><surname>da Silva</surname><given-names>LN</given-names></name><name><surname>Pinheiro</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Mortality Risk After Cardiac Surgery: Application of Inscor in a
University Hospital in Brazil's Northeast</article-title><source>Braz J Cardiovasc Surg</source><year>2016</year><volume>31</volume><issue>5</issue><fpage>396</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.5935/1678-9741.20160080</pub-id><pub-id pub-id-type="pmid">27982349</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros e Silva</surname><given-names>PG</given-names></name><name><surname>Baruzzi</surname><given-names>AC</given-names></name><name><surname>Ramos</surname><given-names>DL</given-names></name><name><surname>Okada</surname><given-names>MY</given-names></name><name><surname>Garcia</surname><given-names>JC</given-names></name><name><surname>Cardoso</surname><given-names>F de A</given-names></name><etal/></person-group><article-title>Improving Indicators in a Brazilian Hospital Through
Quality-Improvement Programs Based on STS Database Reports</article-title><source>Braz J Cardiovasc Surg</source><year>2015</year><volume>30</volume><issue>6</issue><fpage>660</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.5935/1678-9741.20150075</pub-id><pub-id pub-id-type="pmid">26934408</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farkouh</surname><given-names>ME</given-names></name><name><surname>Domanski</surname><given-names>M</given-names></name><name><surname>Sleeper</surname><given-names>LA</given-names></name><name><surname>Siami</surname><given-names>FS</given-names></name><name><surname>Dangas</surname><given-names>G</given-names></name><name><surname>Mack</surname><given-names>M</given-names></name><etal/></person-group><article-title>Strategies for multivessel revascularization in patients with
diabetes</article-title><source>N Engl J Med</source><year>2012</year><volume>367</volume><issue>25</issue><fpage>2375</fpage><lpage>2384</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1211585</pub-id><pub-id pub-id-type="pmid">23121323</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bocchini</surname><given-names>B</given-names></name></person-group><source>Pesquisa mostra que quase 70% dos brasileiros n&#x000e3;o t&#x000ea;m
plano de sa&#x000fa;de particular</source><year>2018</year><publisher-loc>Bras&#x000ed;lia</publisher-loc><publisher-name>Empresa Brasil de Comunica&#x000e7;&#x000e3;o</publisher-name><date-in-citation content-type="access-date">2019 Feb 22</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://agenciabrasil.ebc.com.br/geral/noticia/2018-02/pesquisa-mostra-que-quase-70-dos-brasileiros-nao-tem-plano-de-saude-particular">http://agenciabrasil.ebc.com.br/geral/noticia/2018-02/pesquisa-mostra-que-quase-70-dos-brasileiros-nao-tem-plano-de-saude-particular</ext-link></comment></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hossne Junior</surname><given-names>NA</given-names></name><name><surname>Miranda</surname><given-names>M</given-names></name><name><surname>Monteiro</surname><given-names>MR</given-names></name><name><surname>Branco</surname><given-names>JN</given-names></name><name><surname>Vargas</surname><given-names>GF</given-names></name><name><surname>Pestana</surname><given-names>JO</given-names></name><etal/></person-group><article-title>Cardiopulmonary bypass increases the risk of vasoplegic syndrome
after coronary artery bypass grafting in patients with dialysis-dependent
chronic renal failure</article-title><source>Rev Bras Circ Cardiovasc</source><year>2015</year><volume>30</volume><issue>4</issue><fpage>482</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.5935/1678-9741.20140092</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwann</surname><given-names>TA</given-names></name><name><surname>Tatoulis</surname><given-names>J</given-names></name><name><surname>Puskas</surname><given-names>J</given-names></name><name><surname>Bonnell</surname><given-names>M</given-names></name><name><surname>Taggart</surname><given-names>D</given-names></name><name><surname>Kurlansky</surname><given-names>P</given-names></name><etal/></person-group><article-title>Worldwide Trends in Multi-arterial Coronary Artery Bypass
Grafting Surgery 2004-2014: A Tale of 2 Continents</article-title><source>Semin Thorac Cardiovasc Surg</source><year>2017</year><volume>29</volume><issue>3</issue><fpage>273</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1053/j.semtcvs.2017.05.018</pub-id><pub-id pub-id-type="pmid">29195570</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deutsch</surname><given-names>O</given-names></name><name><surname>Gansera</surname><given-names>L</given-names></name><name><surname>Wunderlich</surname><given-names>M</given-names></name><name><surname>Eichinger</surname><given-names>W</given-names></name><name><surname>Gansera</surname><given-names>B</given-names></name></person-group><article-title>Does Bilateral ITA Grafting Increase Perioperative Complications?
Outcome of 6,476 Patients with Bilateral versus 5,020 Patients with Single
ITA Bypass</article-title><source>Thorac Cardiovasc Surg</source><year>2016</year><volume>64</volume><issue>3</issue><fpage>188</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1055/s-0035-1558992</pub-id><pub-id pub-id-type="pmid">26270198</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ElBardissi</surname><given-names>AW</given-names></name><name><surname>Aranki</surname><given-names>SF</given-names></name><name><surname>Sheng</surname><given-names>S</given-names></name><name><surname>O'Brien</surname><given-names>SM</given-names></name><name><surname>Greenberg</surname><given-names>CC</given-names></name><name><surname>Gammie</surname><given-names>JS</given-names></name></person-group><article-title>Trends in isolated coronary artery bypass grafting: an analysis
of the Society of Thoracic Surgeons adult cardiac surgery
database</article-title><source>J Thorac Cardiovasc Surg</source><year>2012</year><volume>143</volume><issue>2</issue><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2011.10.029</pub-id><pub-id pub-id-type="pmid">22248680</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>WJ</given-names></name><name><surname>Mendonca</surname><given-names>JT</given-names></name><name><surname>Braile</surname><given-names>DM</given-names></name></person-group><article-title>Cardiovascular surgery outcomes opportunity to rediscuss medical
and cardiological care in the Brazilian public health system</article-title><source>Rev Bras Cir Cardiovasc</source><year>2007</year><volume>22</volume><issue>4</issue><fpage>iii</fpage><lpage>ivi</lpage><pub-id pub-id-type="doi">10.1590/S0102-76382007000400002</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Hua</surname><given-names>K</given-names></name><etal/></person-group><article-title>The Chinese Cardiac Surgery Registry: Design and Data
Audit</article-title><source>Ann Thorac Surg</source><year>2016</year><volume>101</volume><issue>4</issue><fpage>1514</fpage><lpage>1520</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2015.09.038</pub-id><pub-id pub-id-type="pmid">26652141</pub-id></element-citation></ref></ref-list></back></article>